Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Subash C. Gupta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0418-1940; OpenAlex author ID A5032514627. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 4

  1. Epoxyazadiradione, a neem-derived limonoid exhibits activities against pancreatic cancer through modulation of inflammatory molecules, lncRNAs, ROS, and EMT. Last author DOI 10.1016/j.bbagen.2026.130938↗
  2. Bharangin, A Diterpenoid, Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine Through Involvement of Long Non-Coding RNAs and Nuclear Factor-κB. Last author DOI 10.1111/1440-1681.70097↗
  3. MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. Co-author DOI 10.1038/s41389-018-0031-0↗
  4. Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppressio… Co-author DOI 10.18632/oncotarget.7537↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nikee Awasthee · 1 shared paper, 2026 · strength 0.43
  2. Vipin Rai · 1 shared paper, 2026 · strength 0.39
  3. Meena Jaggi · 1 shared paper, 2018 · strength 0.09
  4. Murali Mohan Yallapu · 1 shared paper, 2018 · strength 0.09
  5. Sonam Kumari · 1 shared paper, 2018 · strength 0.09
  6. Vivek Kumar Kashyap · 1 shared paper, 2018 · strength 0.09
  7. Subhash C. Chauhan · 1 shared paper, 2018 · strength 0.09
  8. Sheema Khan · 1 shared paper, 2018 · strength 0.09
  9. Sahdeo Prasad · 1 shared paper, 2016 · strength 0.07
  10. Bharat Bhushan Aggarwal · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.